Yüklüyor......
Pharmacokinetics and pharmacodynamics of oral tolvaptan in patients with varying degrees of renal function
The selective vasopressin V2–receptor antagonist tolvaptan is eliminated almost exclusively by non-renal mechanisms. As renal impairment can influence the pharmacokinetics of drugs even when eliminated by non-renal mechanisms, we evaluated the effect of renal insufficiency on the pharmacokinetics/ph...
Kaydedildi:
| Asıl Yazarlar: | , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Nature Publishing Group
2014
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3973039/ https://ncbi.nlm.nih.gov/pubmed/24048380 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/ki.2013.350 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|